Noveris Health Sciences (FRA:0NF1) GF Score: 22/100 (As of Jul. 12, 2026) — 31% Below Median


FRA:0NF1 Noveris Health Sciences Inc FRA:0NF1
22 GF Score
Price €1.01
View Full Analysis

What is Noveris Health Sciences GF Score?

Noveris Health Sciences FRA:0NF1 -0.98% 22 GF Score is 22 as of Jul. 12, 2026, which is 31% below its 10-year median of 32.00. GuruFocus rates FRA:0NF1 with a GF Score™ of 22/100.

Noveris Health Sciences has the GF Score of 22, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 2/10
5. Momentum Rank : 2/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Noveris Health Sciences might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Noveris Health Sciences  (FRA:0NF1) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Noveris Health Sciences GF Score Related Terms

FRA:0NF1 vs ZTS, UTHR: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Noveris Health Sciences's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noveris Health Sciences GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Noveris Health Sciences's GF Score distribution charts can be found below:

* The bar in red indicates where Noveris Health Sciences's GF Score falls into.


FRA:0NF1
22GF Score
Noveris Health Sciences Inc FRA:0NF1
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 22 mean?
Noveris Health Sciences (FRA:0NF1) has a GF Score of 22 as of Jul. 12, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Noveris Health Sciences and its competitors. This is 31% below median its historical median of 32.00. Over the past decade, Noveris Health Sciences' GF Score has ranged from 2.00 to 49.00.
Is Noveris Health Sciences' GF Score too high?
Noveris Health Sciences' current GF Score of 22 is 31% below median its 10-year median of 32.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 49.00. Overall, Noveris Health Sciences has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Noveris Health Sciences' GF Score compare to ZTS and UTHR?
Noveris Health Sciences' GF Score of 22 can be compared against companies in the Drug Manufacturers industry. Historically, Noveris Health Sciences' own GF Score has ranged from 2.00 to 49.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Noveris Health Sciences and its competitors. Noveris Health Sciences's current GF Score is 22, which is 31% below median its own 10-year median of 32.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noveris Health Sciences stock overvalued right now?
Noveris Health Sciences (FRA:0NF1) has a current GF Score of 22. The current GF Score is 22, which is 31% below median its 10-year median of 32.00. Noveris Health Sciences' overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Noveris Health Sciences (FRA:0NF1), the current GF Score is 22 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Noveris Health Sciences Business Description

Other Exchanges MYCOF:USANVRS:Canada
Address 1890 - 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9
Noveris Health Sciences Inc is a biotech and life sciences company dedicated to developing and commercializing solutions for treating mental health problems and enhancing vitality. The company has a portfolio of patents it is seeking to commercialize, and is exploring opportunities in the stem cell industry. It is developing the next generation of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD).
22GF Score

Get the complete analysis for FRA:0NF1

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.01
Price